A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer

This publication has 14 references indexed in Scilit:

• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
  Published by Elsevier ,2021
• Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
  Journal of Clinical Oncology, 1999
• Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma
  Annals of Oncology, 1997
• Cytotoxic Effects of Topotecan Combined With Various Anticancer Agents in Human Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1996
• Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan
  British Journal of Cancer, 1995
• Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
  Journal of Clinical Oncology, 1994
• Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells
  European Journal Of Cancer, 1992
• Effect of specific enzyme inhibitors on replication, total genome DNA repair and on gene-specific DNA repair after UV irradiation in CHO cells
  Mutation Research/DNA Repair, 1991
• Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
  Molecular and Cellular Biology, 1988
• Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
  Molecular and Cellular Biology, 1986